ArticleNanomaterials (Basel, Switzerland)2023
Anti-Icing Property of Superhydrophobic Nanostructured Brass via Deposition of Silica Nanoparticles and Nanolaser Treatment.
Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Water Harvesting Performance of Modified Nanostructure Aluminum Using Silica Nanoparticles Coating and Laser Processing.Nanomaterials (Basel, Switzerland) · 2025Article
- Wetting Transition from Wenzel to Cassie States: Thermodynamic Analysis.Materials (Basel, Switzerland) · 2025Article
- Theoretical Analysis of Contact Angle and Contact Angle Hysteresis of Wenzel Drops on Superhydrophobic Surfaces.Nanomaterials (Basel, Switzerland) · 2024Article
- Advancements in Nanoparticle Deposition Techniques for Diverse Substrates: A Review.Nanomaterials (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Ice accumulation on brass surfaces can lead to heat transfer inefficiency, equipment degradation, and potential accidents. To address this issue, superhydrophobic surface technology is utilized. This work aims to develop superhydrophobic nanostructured brass surfaces using the combination of nanolaser ablation and the deposition of silica nanoparticles to achieve the anti-icing property. Four distinct types of brass surfaces namely, the bare surface (BS), the lasered surface (LS), the coated surface (CS), and the coated-lasered surface (CLS) were prepared. The anti-icing performances of the fabricated samples including the effects of the surface structure, the droplet size, and the surface temperature were investigated and evaluated. The results showed that the delayed icing time increased with the increases in the apparent contact angle, the droplet size, and the surface temperature. When the apparent contact angle increased, the contact area between the droplet and the cooling substrate reduced, leading to the longer delayed icing time. With the deposition of silica nanoparticles and nanolaser treatment, CLS achieved the greatest apparent contact angle of 164.5°, resulting in the longest delayed icing time under all experimental conditions. The longest delayed icing time on CLS recorded in this study was 2584 s, which was 575%, 356%, and 27% greater than those on BS, LS, and CS, respectively. The study also revealed that the surface structure played a more crucial role in achieving the anti-icing property when compared to the surface temperature or the droplet size. The shortest delayed icing time on CLS at the lowest surface temperature and at the smallest droplet size was longer than those on BS and LS at all conditions. The results were also discussed in relation to a heat transfer model. The findings of this research can serve as an avenue for advancing knowledge on heat transfer enhancement and energy efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.